Markets & Regulations

(metamorworks/iStock via Getty Images Plus)

People on the Move: November 2020

By Jenni Spinner

The most recent news on pharmaceutical industry hires, promotions, acquisitions and other events includes Lonza, Medidata, Vetter, and Almac Group.

(peterschreiber.media/iStock via Getty Images Plus)

FDA okays first COVID-19 treatment

By Jenni Spinner

The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.

(olegback/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.

(IrinaBraga/iStock via Getty Images Plus)

SPI Pharma taps Thomson as CEO

By Jenni Spinner

The pharma ingredients company has named veteran Scott Thomson, a 29-year veteran with chemicals firm BASF, to its executive leadership team.

(ismagilov/iStock via Getty Images Plus)

Current FDA COVID-19 advice and actions

By Jenni Spinner

The federal government continues to offer life-sciences professionals advice and resources as they pursue treatments to help fight the COVID-19 virus.

(fizkes/iStock via Getty Images Plus)

CPhI Festival of Pharma

CPhI, Pharmapack Europe to return in 2021

By Jenni Spinner

The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.

 (narith_2527/iStock via Getty Images Plus)

People on the Move: October 2020

By Jenni Spinner

The latest news on pharmaceutical industry hires, promotions, acquisitions and other events includes Medable, Eversana, Parexel, Astellas and more.

(Egor Shabanov/iStock via Getty Images Plus)

FDA COVID-19 response roundup

By Jenni Spinner

As the pandemic maintains its hold, the US agency continues to issue advice and take action related to testing, treatment and information on the virus.

(Vacclav/iStock via Getty Images Plus)

Trump and COVID-19: treatments to date

By Jenni Spinner

With the virus reaching the Oval Office, the presidential diagnosis is shining a spotlight on some of the drugs reportedly administered to the POTUS.

Follow us

Products

View more

Webinars